Pharmacokinetics of Intranasally Administered Dexmedetomidine in Chinese Children
Background: Intranasal application is a comfortable, effective, nearly non-invasive, and easy route of administration in children. To date, there is, however, only one pharmacokinetic study on intranasal dexmedetomidine in pediatric populations and none in Chinese children available. Therefore, this...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00756/full |
id |
doaj-d8ab18ca9f2840d281fcae6f2bb2c113 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Cheng-Yu Wang Cheng-Yu Wang Harald Ihmsen Zhi-Yan Hu Zhi-Yan Hu Jia Chen Jia Chen Xue-Fei Ye Xue-Fei Ye Fang Chen Fang Chen Yi Lu Yi Lu Jürgen Schüttler Qing-Quan Lian Qing-Quan Lian Hua-Cheng Liu Hua-Cheng Liu |
spellingShingle |
Cheng-Yu Wang Cheng-Yu Wang Harald Ihmsen Zhi-Yan Hu Zhi-Yan Hu Jia Chen Jia Chen Xue-Fei Ye Xue-Fei Ye Fang Chen Fang Chen Yi Lu Yi Lu Jürgen Schüttler Qing-Quan Lian Qing-Quan Lian Hua-Cheng Liu Hua-Cheng Liu Pharmacokinetics of Intranasally Administered Dexmedetomidine in Chinese Children Frontiers in Pharmacology dexmedetomidine intranasal pharmacokinetics pediatrics Chinese |
author_facet |
Cheng-Yu Wang Cheng-Yu Wang Harald Ihmsen Zhi-Yan Hu Zhi-Yan Hu Jia Chen Jia Chen Xue-Fei Ye Xue-Fei Ye Fang Chen Fang Chen Yi Lu Yi Lu Jürgen Schüttler Qing-Quan Lian Qing-Quan Lian Hua-Cheng Liu Hua-Cheng Liu |
author_sort |
Cheng-Yu Wang |
title |
Pharmacokinetics of Intranasally Administered Dexmedetomidine in Chinese Children |
title_short |
Pharmacokinetics of Intranasally Administered Dexmedetomidine in Chinese Children |
title_full |
Pharmacokinetics of Intranasally Administered Dexmedetomidine in Chinese Children |
title_fullStr |
Pharmacokinetics of Intranasally Administered Dexmedetomidine in Chinese Children |
title_full_unstemmed |
Pharmacokinetics of Intranasally Administered Dexmedetomidine in Chinese Children |
title_sort |
pharmacokinetics of intranasally administered dexmedetomidine in chinese children |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Pharmacology |
issn |
1663-9812 |
publishDate |
2019-07-01 |
description |
Background: Intranasal application is a comfortable, effective, nearly non-invasive, and easy route of administration in children. To date, there is, however, only one pharmacokinetic study on intranasal dexmedetomidine in pediatric populations and none in Chinese children available. Therefore, this study aimed to characterize the pharmacokinetics of intranasally administered dexmedetomidine in Chinese children.Methods: Thirteen children aged 4 to 10 years undergoing surgery received 1 µg/kg dexmedetomidine intranasally. Arterial blood samples were drawn at various time points until 180 min after dose. Dexmedetomidine plasma concentrations were measured with high performance liquid chromatography (HPLC) and mass spectrometry. Pharmacokinetic modeling was performed by population analysis using linear compartment models with first-order absorption.Results: An average peak plasma concentration of 748 ± 30 pg/ml was achieved after 49.6 ± 7.2 min. The pharmacokinetics of dexmedetomidine was best described by a two-compartment model with first-order absorption and an allometric scaling with estimates standardized to 70-kg body weight. The population estimates (SE) per 70 kg bodyweight of the apparent pharmacokinetic parameters were clearance CL/F = 0.32 (0.02) L/min, central volume of distribution V1/F = 34.2 (4.9) L, intercompartmental clearance Q2/F = 10.0 (2.2) L/min, and peripheral volume of distribution V2/F = 34.9 (2.3) L. The estimated absorption rate constant was Ka = 0.038 (0.004) min−1.Conclusions: When compared with studies in Caucasians, Chinese children showed a similar time to peak plasma concentration after intranasal administration, but the achieved plasma concentrations were about three times higher. Possible reasons are differences in age, ethnicity, and mode of administration. |
topic |
dexmedetomidine intranasal pharmacokinetics pediatrics Chinese |
url |
https://www.frontiersin.org/article/10.3389/fphar.2019.00756/full |
work_keys_str_mv |
AT chengyuwang pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren AT chengyuwang pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren AT haraldihmsen pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren AT zhiyanhu pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren AT zhiyanhu pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren AT jiachen pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren AT jiachen pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren AT xuefeiye pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren AT xuefeiye pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren AT fangchen pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren AT fangchen pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren AT yilu pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren AT yilu pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren AT jurgenschuttler pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren AT qingquanlian pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren AT qingquanlian pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren AT huachengliu pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren AT huachengliu pharmacokineticsofintranasallyadministereddexmedetomidineinchinesechildren |
_version_ |
1725383299987144704 |
spelling |
doaj-d8ab18ca9f2840d281fcae6f2bb2c1132020-11-25T00:16:19ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122019-07-011010.3389/fphar.2019.00756464117Pharmacokinetics of Intranasally Administered Dexmedetomidine in Chinese ChildrenCheng-Yu Wang0Cheng-Yu Wang1Harald Ihmsen2Zhi-Yan Hu3Zhi-Yan Hu4Jia Chen5Jia Chen6Xue-Fei Ye7Xue-Fei Ye8Fang Chen9Fang Chen10Yi Lu11Yi Lu12Jürgen Schüttler13Qing-Quan Lian14Qing-Quan Lian15Hua-Cheng Liu16Hua-Cheng Liu17Department of Anesthesiology, Perioperative and Pain Medicine, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaKey Laboratory of Anesthesiology of Zhejiang Province, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaDepartment of Anesthesiology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, GermanyDepartment of Anesthesiology, Perioperative and Pain Medicine, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaKey Laboratory of Anesthesiology of Zhejiang Province, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaDepartment of Anesthesiology, Perioperative and Pain Medicine, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaKey Laboratory of Anesthesiology of Zhejiang Province, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaDepartment of Anesthesiology, Perioperative and Pain Medicine, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaKey Laboratory of Anesthesiology of Zhejiang Province, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaDepartment of Anesthesiology, Perioperative and Pain Medicine, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaKey Laboratory of Anesthesiology of Zhejiang Province, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaDepartment of Anesthesiology, Perioperative and Pain Medicine, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaKey Laboratory of Anesthesiology of Zhejiang Province, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaDepartment of Anesthesiology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, GermanyDepartment of Anesthesiology, Perioperative and Pain Medicine, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaKey Laboratory of Anesthesiology of Zhejiang Province, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaDepartment of Anesthesiology, Perioperative and Pain Medicine, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaKey Laboratory of Anesthesiology of Zhejiang Province, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, ChinaBackground: Intranasal application is a comfortable, effective, nearly non-invasive, and easy route of administration in children. To date, there is, however, only one pharmacokinetic study on intranasal dexmedetomidine in pediatric populations and none in Chinese children available. Therefore, this study aimed to characterize the pharmacokinetics of intranasally administered dexmedetomidine in Chinese children.Methods: Thirteen children aged 4 to 10 years undergoing surgery received 1 µg/kg dexmedetomidine intranasally. Arterial blood samples were drawn at various time points until 180 min after dose. Dexmedetomidine plasma concentrations were measured with high performance liquid chromatography (HPLC) and mass spectrometry. Pharmacokinetic modeling was performed by population analysis using linear compartment models with first-order absorption.Results: An average peak plasma concentration of 748 ± 30 pg/ml was achieved after 49.6 ± 7.2 min. The pharmacokinetics of dexmedetomidine was best described by a two-compartment model with first-order absorption and an allometric scaling with estimates standardized to 70-kg body weight. The population estimates (SE) per 70 kg bodyweight of the apparent pharmacokinetic parameters were clearance CL/F = 0.32 (0.02) L/min, central volume of distribution V1/F = 34.2 (4.9) L, intercompartmental clearance Q2/F = 10.0 (2.2) L/min, and peripheral volume of distribution V2/F = 34.9 (2.3) L. The estimated absorption rate constant was Ka = 0.038 (0.004) min−1.Conclusions: When compared with studies in Caucasians, Chinese children showed a similar time to peak plasma concentration after intranasal administration, but the achieved plasma concentrations were about three times higher. Possible reasons are differences in age, ethnicity, and mode of administration.https://www.frontiersin.org/article/10.3389/fphar.2019.00756/fulldexmedetomidineintranasalpharmacokineticspediatricsChinese |